Translational highlights in breast cancer research and treatment: recent developments with clinical impact

Purpose of reviewOver the last decades the time which is needed to translate a preclinical finding or idea in the clinic has reduced continuously. Especially but not only for breast cancer the number of tested drugs and targeted pathways have increased immensely. In addition, the introduction of imm

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Fasching, Peter Andreas (VerfasserIn) , Schneeweiss, Andreas (VerfasserIn) , Kolberg, Hans-Christian (VerfasserIn) , Ettl, Johannes (VerfasserIn) , Fehm, Tanja (VerfasserIn) , Overkamp, Friedrich (VerfasserIn) , Lüftner, Diana (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 2019/02/01
In: Current opinion in obstetrics and gynecology
Year: 2019, Jahrgang: 31, Heft: 1, Pages: 67-75
ISSN:1473-656X
DOI:10.1097/GCO.0000000000000510
Online-Zugang:Verlag, Volltext: https://doi.org/10.1097/GCO.0000000000000510
Volltext
Verfasserangaben:Peter A. Fasching, Andreas Schneeweiss, Hans-Christian Kolberg, Johannes Ettl, Tanja Fehm, Friedrich Overkamp, and Diana Lüftner
Beschreibung
Zusammenfassung:Purpose of reviewOver the last decades the time which is needed to translate a preclinical finding or idea in the clinic has reduced continuously. Especially but not only for breast cancer the number of tested drugs and targeted pathways have increased immensely. In addition, the introduction of imm
Beschreibung:Gesehen am 10.07.2019
Beschreibung:Online Resource
ISSN:1473-656X
DOI:10.1097/GCO.0000000000000510